High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.
暂无分享,去创建一个
William King | Jeffrey W Pollard | J. Pollard | Laureen S Ojalvo | Dianne Cox | D. Cox | L. Ojalvo | W. King
[1] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[2] P. Validire,et al. Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer. , 1994, British Journal of Cancer.
[3] S M Schwartz,et al. Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.
[4] F. Beuvon,et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. , 1994, Journal of the National Cancer Institute.
[5] E. Manseau,et al. Osteopontin expression and distribution in human carcinomas. , 1994, The American journal of pathology.
[6] B. Kacinski,et al. CSF-1 and its receptor in ovarian, endometrial and breast cancer. , 1995, Annals of medicine.
[7] G. Stamp,et al. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. , 1995, The Journal of clinical investigation.
[8] J. Pollard,et al. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] Ross Ihaka,et al. Gentleman R: R: A language for data analysis and graphics , 1996 .
[10] R. Jakesz,et al. Tumour-associated macrophages in breast cancer and their prognostic correlations , 1998 .
[11] J. F. Harris,et al. Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.
[12] C. Murry,et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.
[13] S. Nishikawa,et al. Macrophage Lineage Cells in Inflammation: Characterization by Colony-Stimulating Factor-1 (CSF-1) Receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) Expression , 1998 .
[14] S. Nishikawa,et al. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. , 1998, Blood.
[15] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Lo,et al. Influence of lymphocytes on the presence and organization of dendritic cell subsets in the spleen. , 1999, Journal of immunology.
[17] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[18] J. Pollard,et al. Postnatal mammary gland development requires macrophages and eosinophils. , 2000, Development.
[19] H. Saji,et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[22] H. Saji,et al. Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.
[23] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[24] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[25] J. Pollard,et al. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development , 2002, Breast Cancer Research.
[26] E. Stanley,et al. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. , 2002, Cancer research.
[27] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[28] Michael C. Ostrowski,et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. , 2003, Blood.
[29] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[30] Jeffrey W Pollard,et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.
[31] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[32] L. Trümper,et al. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.
[33] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[34] A. Chambers,et al. Role of osteopontin in tumour progression , 2004, British Journal of Cancer.
[35] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[36] Andrew V. Nguyen,et al. The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.
[37] A. Harris,et al. Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.
[38] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[39] T. Barrette,et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.
[40] J. Gregg,et al. Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior , 2005, Clinical & Experimental Metastasis.
[41] Erik Sahai,et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.
[42] R. Irby,et al. Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progression , 2005, Molecular carcinogenesis.
[43] B. Nielsen,et al. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. , 2005, Carcinogenesis.
[44] T. Hagemann,et al. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. , 2005, Journal of immunology.
[45] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[46] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[47] T. Hagemann,et al. Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1 , 2005, The Journal of Immunology.
[48] S Gordon,et al. Macrophage receptors and immune recognition. , 2005, Annual review of immunology.
[49] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[50] B. Isaac,et al. Syk Is Required for Monocyte/Macrophage Chemotaxis to CX3CL1 (Fractalkine)1 , 2005, The Journal of Immunology.
[51] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[52] L. Trümper,et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Pollard,et al. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[54] J. Pollard,et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.
[55] A. Sica,et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.
[56] J. Pollard,et al. Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.
[57] S. Gordon,et al. Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.
[58] S. R. Himes,et al. Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony‐stimulating factor receptor (CSF‐1R) as well as many other macrophage‐specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF‐1 , 2007, Journal of leukocyte biology.
[59] T. Barrette,et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.
[60] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[61] J. Suttles,et al. IL-12 Rapidly Alters the Functional Profile of Tumor-Associated and Tumor-Infiltrating Macrophages In Vitro and In Vivo1 , 2007, The Journal of Immunology.
[62] Yarong Wang,et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.
[63] Alberto Mantovani,et al. Inflammation and cancer: breast cancer as a prototype. , 2007, Breast.
[64] J. Pollard,et al. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages , 2007, Molecular oncology.
[65] N. Minato,et al. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion , 2007, Nature Genetics.
[66] J. Pollard,et al. Tumor-associated macrophages press the angiogenic switch in breast cancer. , 2007, Cancer research.
[67] D. Hume,et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. , 2007, Developmental biology.
[68] L. Rodrigues,et al. The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[69] P. Comoglio,et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.
[70] T. Lawrence,et al. “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.
[71] D. Ovchinnikov. Macrophages in the embryo and beyond: Much more than just giant phagocytes , 2008, Genesis.
[72] D. Carbone,et al. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.
[73] H. Saya,et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells , 2008, The EMBO journal.
[74] V. Bronte,et al. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.
[75] Michelle Collazo,et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.
[76] R. Weinberg,et al. Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.